Home‎ > ‎



  1. D.M.F. van Aalten, A. Amadei, A.B.M. Linssen, V.G.H. Eijsink, G. Vriend, and H.J.C. Berendsen, "The essential dynamics of thermolysin - confirmation of the hinge-bending motion and comparison of simulations in vacuum and water", Proteins (1995), 22, 45-54.
  2. D.M.F. van Aalten, J.B.C. Findlay, A. Amadei, and H.J.C. Berendsen, "Essential dynamics of the cellular retinol-binding protein - evidence for ligand-induced conformational changes", Prot. Engng. (1995), 8, 1129-1135


  1. D.M.F. van Aalten, A. Amadei, R. Bywater, J.B.C. Findlay, H.J.C. Berendsen, C. Sander, and P.F.W. Stouten, "A comparison of structural and dynamic properties of different simulation methods applied to SH3", Biophys. J. (1996), 70, 684-692.
  2. A. Amadei, A.B.M. Linssen, B.L. de Groot, D.M.F. van Aalten, and H.J.C. Berendsen, "An efficient method for sampling the essential subspace of proteins", J. Biomol. Str. Dyn. (1996), 13, 615-625.
  3. B.L. de Groot, A. Amadei, D.M.F. van Aalten, and H.J.C. Berendsen, "Towards an exhaustive sampling of the configurational spaces of the two forms of the peptide hormone guanylin", J. Biomol. Str. Dyn. (1996), 13, 741-751.
  4. D.M.F. van Aalten, R. Bywater, J.B.C. Findlay, M. Hendlich, R.W.W. Hooft, and G. Vriend, "PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules", JCAMD (1996), 10, 255-262. Postscript
  5. B.L. de Groot, D.M.F. van Aalten, A. Amadei, and H.J.C. Berendsen, "The consistency of large concerted motions in proteins in molecular dynamics simulations", Biophys. J. (1996), 71, 1707-1713. PDF
  6. D.M.F. van Aalten, B.L. de Groot, H.J.C. Berendsen, and J.B.C. Findlay, "Conformational analysis of retinoids and restriction of their dynamics by retinoid-binding proteins", Biochem. J. (1996), 319, 543-550. PDF
  7. G.H. Peters, D.M.F. van Aalten, O. Edholm, S. Toxvaerd, and R. Bywater, "Dynamics of proteins in different solvent systems: Analysis of essential motion in lipases", Biophys. J. (1996), 71, 2245-2255.

  8. 1997

  9. D.M.F. van Aalten, B.L. de Groot, J.B.C. Findlay, H.J.C. Berendsen, and A. Amadei, "A comparison of techniques for calculating protein essential dynamics", J. Comp. Chem. (1997), 18, 169-181. PDF
  10. D.M.F. van Aalten, P.C. Jones, M. de Sousa, and J.B.C. Findlay, "Engineering protein mechanics: inhibition of concerted motions of the cellular retinol binding protein by site-directed mutagenesis", Prot. Engng. (1997), 10, 31-37. PDF
  11. G.H. Peters, D.M.F. van Aalten, A. Svendsen, and R. Bywater, "Essential dynamics of lipase binding sites: the effect of inhibitors of different chain length", Prot. Engng. (1997), 10, 149-158. PDF
  12. L.V. Mello, D.M.F. van Aalten, and J.B.C. Findlay, "Comparison of ras-p21 bound to GDP and GTP: differences in protein and ligand dynamics", Prot. Engng. (1997), 10, 381-387. PDF
  13. B.L. de Groot, D.M.F. van Aalten, R.M. Scheek, A. Amadei, G. Vriend, and H.J.C. Berendsen, "Prediction of protein conformational freedom from distance constraints", Proteins (1997), 29, 240-251. PDF
  14. D.M.F. van Aalten, D.A. Conn, B.L. de Groot, H.J.C. Berendsen, J.B.C. Findlay, and A. Amadei, "Protein dynamics derived from clusters of crystal structures", Biophys. J. (1997), 73, 2891-2896. PDF

  15. 1998

  16. L.V. Mello, D.M.F. van Aalten, and J.B.C. Findlay, "Dynamic properties of the guanine nucleotide binding protein alpha subunit and comparison of its guanosine triphosphate hydrolase domain with that of ras-p21", Biochemistry (1998), 37, 3137-3142. PDF
  17. B.L. de Groot, S. Hayward, D.M.F. van Aalten, A. Amadei, and H.J.C. Berendsen, "Domain motions in bacteriophage T4 lysozyme: A comparison between molecular dynamics and crystallographic data", Proteins (1998), 31, 116-127. PDF
  18. H. Yamaguchi, D.M.F. van Aalten, M. Pinak, A. Furukawa, and R. Osman, "Essential dynamics of DNA containing a cis.syn cyclobutane thymine dimer lesion", Nucl. Acids Res. (1998), 26, 1939-1946. PDF
  19. D.M.F. van Aalten, E. Grotewold, and L. Joshua-Tor, "Essential dynamics from NMR clusters: dynamic properties of the Myb DNA-binding domain and a hinge-bending enhancing variant", Methods (1998), 14, 318-328. PDF
  20. R. Kort, M.K. Phillips-Jones, D.M.F. van Aalten, A. Haker, S.M. Hoffer, K.J. Hellingwerf, and W. Crielaard, "Sequence, chromophore extraction and 3-D model of the photoactive yellow protein from Rhodobacter sphaeroides", Biochim. Biophys. Acta (1998), 1385, 1-6. PDF
  21. M. Sundaram, A. Sivaprasadarao, D.M.F. van Aalten, and J.B.C. Findlay, "Expression, characterization and engineered specificity of rat epididymal retinoic acid-binding protein", Biochem. J. (1998), 334, 155-160. PDF
  22. D.M.F. van Aalten, W.D. Hoff, J.B.C. Findlay, W. Crielaard, and K.J. Hellingwerf, "Concerted motions in the photoactive yellow protein", Prot. Engng. (1998), 11, 873-879. PDF

  23. 1999

  24. P.-L. Chau, D.M.F. van Aalten, J.B.C. Findlay, and R.P. Bywater, "Functional concerted motions in the bovine serum retinol-binding protein", JCAMD (1999), 13, 11-20.
  25. D.M.F. van Aalten, D.A. Erlanson, G.L. Verdine, and L. Joshua-Tor, "A structural snapshot of base-pair opening in DNA", Proc. Natl. Acad. Sci. USA (1999), 96, 11809-1814. PDF

  26. 2000

  27. D.M.F. van Aalten, W. Crielaard, K.J. Hellingwerf, and L. Joshua-Tor, "Conformational substates in different crystal forms of the photoactive yellow protein - correlation with theoretical and experimental flexibility", Protein Science (2000), 9, 64-72. PDF
  28. P.J.L. Werten, B. Roll, D.M.F. van Aalten, and W.W. de Jong, "Gecko iota-crystallin: How cellular retinol-binding protein became an eye lens ultraviolet filter", Proc. Natl. Acad. Sci. USA (2000), 97, 3282-3287. PDF
  29. D.M.F. van Aalten, J.Knudsen, C.C. DiRusso, T. Kokko, and R. Wierenga, "Crystallization and X-ray diffraction studies of the fatty acid responsive transcription factor FadR from Escherichia coli", Acta Cryst. (2000), D56, 469-471. PDF
  30. D.M.F. van Aalten, B. Synstad, M.B. Brurberg, E. Hough, B.W. Riise, V.G.H. Eijsink, and R.K. Wierenga, "Structure of a two-domain chitotriosidase from Serratia marcescens at 1.9 Å resolution", Proc. Natl. Acad. Sci. USA (2000), 97, 5842-5847. PDF
  31. A.M. Mursula, D.M.F. van Aalten, Y. Modis, J. K. Hiltunen, and R.K. Wierenga, "Crystallization and X-ray diffraction analysis of peroxisomal D3-D2-enoyl-CoA isomerase from Saccharomyces cerevisiae", Acta Cryst. (2000), D56, 1020-1023. PDF
  32. D.M.F. van Aalten, C.R. Chong, and L. Joshua-Tor, "Crystal structure of carboxypeptidase A complexed with D-cysteine at 1.75 Å - Inhibitor-induced conformational changes", Biochemistry (2000), 39, 10082-10089. PDF
  33. D.M.F. van Aalten, C.C. DiRusso, J. Knudsen, and R.K. Wierenga, "Crystal structure of FadR, a fatty acid-responsive transcription factor with a novel acyl coenzyme A-binding fold", EMBO J. (2000), 19, 5167-5177. PDF

  34. 2001

  35. D.M.F. van Aalten, K.G. Milne, J. Y. Zou, G.J. Kleywegt, T. Bergfors, M.A.J. Ferguson, J. Knudsen, and T.A. Jones, "Binding site differences revealed by crystal structures of Plasmodium falciparum and bovine acyl-CoA binding protein", J. Mol. Biol. (2001), 309, 181-192. PDF
  36. D.M.F. van Aalten, C.C. DiRusso, and J. Knudsen, "The structural basis of acyl coenzyme A-dependent regulation of the transcription factor FadR", EMBO J. (2001), 20, 2041-2050. PDF
  37. M.A.M. van Boekel, D.M.F. van Aalten, G.-J. Caspers, B. Roll, and W.W. de Jong, "Evolution of the aldose reductase-related gecko eye lens protein rho-B-crystallin: a sheep in wolf's clothing", J. Mol. Evol. (2001), 52, 239-248. PDF
  38. A.M. Mursula, D.M.F. van Aalten, J.K. Hiltunen, and R.K. Wierenga, "The crystal structure of D3-D2-enoyl-CoA isomerase", J. Mol. Biol. (2001), 309, 845-853. PDF
  39. D.M.F. van Aalten, D. Komander, B. Synstad, S. Gåseidnes, M.G. Peter, and V.G.H. Eijsink, "Structural insights into the catalytic mechanism of a family 18exo-chitinase", Proc. Natl. Acad. Sci. USA (2001), 98, 8979-8984. PDF
  40. M.B. Brurberg, B. Synstad, S.S. Klemsdal, D.M.F. van Aalten, L. Sundheim, and V.G.H. Eijsink, "Chitinases from Serratia marcescens", Recent Res. Devel. Microbiology (2001), 5, 187-204. PDF
  41. C.C. Thomas, S.J. Dowler, M. Deak, D.R. Alessi, and D.M.F. van Aalten, "Crystal structure of the phosphatidylinositol (3,4)-bisphosphatebinding PH domain of TAPP1 - molecular basis of lipid specificity", Biochem. J. (2001), 358, 287-294. PDF
  42. A.M. Haapalainen, D.M.F. van Aalten, G. Meriläinen, J.E. Jalonen, R.K. Wierenga, J.K. Hiltunen, and T. Glumoff, "Crystal structure of the liganded SCP-2 like domain of humanperoxisomal multifunctional enzyme type 2 at 1.75 Å resolution", J. Mol. Biol. (2001), 313, 1127-1138. PDF

  43. 2002

  44. G. Kolstad, B. Synstad, V.G.H. Eijsink, and D.M.F. van Aalten, "Crystal structure of the D140N mutant of chitinase B from Serratia marcescens at 1.45 Å resolution", Acta Cryst. (2002), D58, 377-379. PDF
  45. J.N. Tabudravu, V.G.H. Eijsink, G.W. Gooday, M. Jaspars, D.Komander, M. Legg, B. Synstad, and D.M.F. van Aalten, "Psammaplin A, a chitinase inhibitor isolated from the Fijian marinesponge Aplysinella rhax", Bioorg. Med. Chem. (2002), 10, 1123-1128. PDF
  46. D.M.F. van Aalten, A. Haker, J. Hendriks, K.J. Hellingwerf, L. Joshua-Tor, and W. Crielaard, "Engineering photocycle dynamics - crystal structures and kinetics of three photoactive yellow protein hinge-bending mutants", J. Biol. Chem. (2002), 277, 6463-6468. PDF
  47. M. Sundaram, D.M.F. van Aalten, J.B.C. Findlay, and A. Sivaprasadarao, "The transfer of transthyretin and receptor-binding properties from the plasma retinol-binding protein to the epididymal retinoic acid-binding protein", Biochem. J. (2002), 362, 265-271. PDF
  48. D.M.F. van Aalten, W. Crielaard, K.J. Hellingwerf, and L. Joshua-Tor, "Structure of the photoactive yellow protein reconstituted with caffeic acid at 1.16 Å resolution", Acta Cryst. (2002), D58, 585-590. PDF
  49. D.R. Houston, K. Shiomi, N. Arai, S. Omura, M.G. Peter, A. Turberg, B. Synstad, V.G.H. Eijsink, and D.M.F. van Aalten, "High-resolution structures of a chitinase complexed with natural product cyclopentapeptide inhibitors: Mimicry of carbohydrate substrate", Proc. Natl. Acad. Sci. USA (2002), 99, 9127-9132. PDF + Commentary PDF
  50. F. Fusetti, H. von Moeller, D. Houston, H.J. Rozeboom, B.W. Dijkstra, R.G. Boot, J.M.F.G. Aerts, and D.M.F. van Aalten, "Structure of human chitotriosidase - implications for specific inhibitor design and function of mammalian chitinase-like lectins", J. Biol. Chem. (2002), 277, 25537-25544. PDF
  51. C.C. Thomas, M. Deak, D.R. Alessi, and D.M.F. van Aalten, "High-resolution structure of the pleckstrin homology domain of protein kinaseB/Akt bound to phosphatidylinositol (3,4,5)-trisphosphate", Curr. Biol. (2002), 12, 1256-1262. PDF
  52. R.M. Biondi, D. Komander, C.C. Thomas, J.M. Lizcano, M. Deak, D.R. Alessi, and D.M.F. van Aalten, "High resolution crystal structure of the human PDK1 catalytic domain defines the regulatory phosphopeptide docking site", EMBO J. (2002), 21, 4219-4228. PDF
  53. D.R. Houston, I. Eggleston, B. Synstad, V.G.H. Eijsink, and D.M.F. van Aalten, "The cyclic dipeptide CI-4 inhibits family 18 chitinases by structural mimicry of a reaction intermediate", Biochem. J. (2002), 368, 23-27. PDF

  54. 2003

  55. M.S. Alphey, H. Attrill, P.R. Crocker, and D.M.F. van Aalten, "High resolution crystal structures of Siglec-7 - insights into ligand specificity in the Siglec family", J. Biol. Chem. (2003), 278, 3372-3377. PDF
  56. F.V. Rao, D.R. Houston, R.G. Boot, J.M.F.G. Aerts, S. Sakuda, and D.M.F. van Aalten, "Crystal structures of allosamidin derivatives in complex with human macrophage chitinase", J. Biol. Chem. (2003), 278, 20110-20116. PDF
  57. J. Vreede, M.A. van der Horst, K.J. Hellingwerf, W. Crielaard, and D.M.F. van Aalten, "PAS domains - common structure, common flexibility?", J. Biol. Chem. (2003), 278, 18434-18439. PDF
  58. D.R. Houston, A.D. Recklies, J.C. Krupa, and D.M.F. van Aalten, "Structure and ligand-induced conformational change of the 39 kD glycoprotein from human articular chondrocytes", J. Biol. Chem. (2003), 278, 30206-30212. PDF
  59. G.J. Kleywegt, K. Henrick, E.J. Dodson, and D.M.F. van Aalten, "Pound-wise but penny-foolish: How well do micromolecules fare in macromolecular refinement?", Structure (2003), 11, 1051-1059. PDF
  60. D. Komander, G.S. Kular, J. Bain, M. Elliott, D.R. Alessi, and D.M.F. van Aalten, "Structural basis for UCN-01 (7-hydroxystaurosporine) specificity and PDK1 (3-phosphoinositide-dependent protein kinase-1) inhibition", Biochem. J. (2003), 375, 255-262. PDF
  61. C.C. Milburn, M. Deak, S.M. Kelly, N.C. Price, D.R. Alessi, and D.M.F. van Aalten, "Binding of phosphatidylinositol 3,4,5-trisphosphate to the Pleckstrin Homology domain of protein kinase B induces a conformational change", Biochem. J. (2003), 375, 531-538. PDF

  62. 2004

  63. G. Vaaje-Kolstad, D.R. Houston, F.V. Rao, M.G. Peter, B. Synstad, D.M.F. van Aalten, and V.G.H. Eijsink, "Structure of the D142N mutant of the family 18 chitinase ChiB from Serratia marcescens and its complex with allosamidin", Biochim. Biophys. Acta (2004), 1696, 103-111. PDF
  64. C.C. Milburn, J. Boudeau, M. Deak, D.R. Alessi, and D.M.F. van Aalten, "Crystal structure of MO25α in complex with the C terminus of the pseudo kinase STE20-related adaptor", Nature Struct. Mol. Biol. (2004),11, 192-200. PDF
  65. D. Komander, G.S. Kular, A.W. Schüttelkopf, M. Deak, K.R.C. Prakash, J. Bain, M. Elliott, M. Garrido-Franco, A.P. Kozikowski, D.R. Alessi, and D.M.F. van Aalten, "Interactions of LY333531 and other bisindolyl maleimide inhibitors with PDK1", Structure (2004), 12, 215-226. PDF
  66. G. Vaaje-Kolstad, A. Vasella, M.G. Peter, C. Netter, D.R. Houston, B. Westereng, B. Synstad, V.G.H. Eijsink, and D.M.F. van Aalten, "Interactions of a family 18 chitinase with the designed inhibitor HM508 and its degradation product, chitobiono-δ-lactone", J. Biol. Chem. (2004), 279, 3612-3619. PDF
  67. B. Synstad, S. Gåseidnes, D.M.F. van Aalten, G. Vriend, J.E. Nielsen, and V.G.H. Eijsink, "Mutational and computational analysis of the role of conserved residues in the active site of a family 18 chitinase", Eur.J.Biochem. (2004), 271, 253-262. PDF
  68. D. Komander, M. Deak, N. Morrice, and D.M.F. van Aalten, "Purification, crystallisation and preliminary X-ray diffraction of aproteolytic fragment of PDK1 containing the pleckstrin homology domain", Acta Cryst. (2004), D60, 314-316. PDF
  69. A. Mora, D. Komander, D.M.F. van Aalten, and D.R. Alessi, "PDK1, the master regulator of AGC kinase signal transduction", Semin. Cell Dev. Biol. (2004), 15, 161-170. PDF
  70. N. Dimasi, H. Attrill, D.M.F. van Aalten, A. Moretta, L. Moretta, R. Biassoni, and R. Mariuzza, "Structure of the saccharide-binding domain of the human natural killer cell inhibitory receptor p75/AIRM1", Acta Cryst. (2004), D60, 620. PDF
  71. A.W. Schuettelkopf and D.M.F. van Aalten, "PRODRG: a tool for high-throughput crystallography of protein-ligandcomplexes", Acta Cryst. (2004), D60, 1355-1363. PDF
  72. D.E. Blair and D.M.F. van Aalten, "Structures of Bacillus subtilis PdaA, a family 4 carbohydrate esterase, and a complex with N-acetyl-glucosamine", FEBS Lett. (2004), 570, 13-19. PDF
  73. D. Komander, A. Fairservice, M. Deak, G.S. Kular, A.R. Prescott, C.P. Downes, S.T. Safrany, D.R. Alessi, and D.M.F. van Aalten, "Structural insights into the regulation of PDK1 by phosphoinositides and inositol phosphates", EMBO J. (2004), 23, 3918-3928. PDF
  74. D.R. Houston, B. Synstad, V.G.H. Eijsink, M.J.R. Stark, I.M. Eggleston, and D.M.F. van Aalten, "Structure-based exploration of cyclic dipeptide chitinase inhibitors", J. Med. Chem. (2004), 47, 5713-5720. PDF
  75. J. Boudeau, J.W. Scott, N. Resta, M. Deak, A. Kieloch, D. Komander, D.G. Hardie, A.R. Prescott, D.M.F. van Aalten, and D.R. Alessi, "Analysis of the LKB1:STRAD:MO25 complex", J. Cell. Sci. (2004), 117, 6365-6375. PDF

  76. 2005

  77. F.V. Rao, D.R. Houston, R.G. Boot, J.M.F.G. Aerts, M. Hodkinson, D.J. Adams, K. Shiomi, S. Omura, and D.M.F. van Aalten, "Specificity and affinity of natural product cyclopentapeptide inhibitors against Aspergillus fumigatus, human and bacterial chitinases", Chem. Biol. (2005), 12, 65-76. PDF + Commentary PDF
  78. F. Villa, M. Deak, G.B. Bloomberg, D.R. Alessi, and D. M.F. van Aalten, "Crystal structure of the PTPL1/FAP-1 human tyrosine phosphatase mutated in colorectal cancer: evidence for a second phosphotyrosine substrate recognition pocket", J. Biol. Chem. (2005), 280, 8180-8187. PDF
  79. G. Vaaje-Kolstad, D.R. Houston, A.H.K. Riemen, V.G.H. Eijsink, and D.M.F. van Aalten, "Crystal structure and binding properties of the Serratia marcescens chitin-binding protein CBP21", J. Biol. Chem. (2005), 280, 11313-11319. PDF
  80. D. Komander, G. Kular, M. Deak, D.R. Alessi, and D.M.F. van Aalten, "Role of T-loop phosphorylation in PDK1 activation, stability and substrate binding", J. Biol. Chem. (2005), 280, 18797-11802. PDF
  81. M.D. Urbaniak, A. Crossman, T. Chang, T.K. Smith, D.M.F. van Aalten, and M.A.J. Ferguson, "The N-acetyl-D-glucosaminylphosphatidylinositol de-N-acetylase of glycosylphosphatidylinositol biosynthesis is a zinc metalloenzyme",J. Biol. Chem. (2005), 280, 22831-22838. PDF
  82. G. Vaaje-Kolstad, S.J. Horn, D.M.F. van Aalten, B. Synstad, and V.G.H. Eijsink, "The non-catalytic chitin-binding protein CBP21 from Serratiamarcescens is essential for chitin degradation", J. Biol. Chem. (2005), 280, 28492-28497. PDF + Commentary PDF
  83. F.V. Rao, O.A. Andersen, K.A. Vora, J.A. DeMartino, and D.M.F. van Aalten, "Methylxanthine drugs are chitinase inhibitors: investigation of inhibition and binding modes", Chem. Biol. (2005), 12, 973-980. PDF
  84. M.J. Dixon, O.A. Andersen, D.M.F. van Aalten, and I.M. Eggleston, "An efficient synthesis of argifin: A natural product chitinase inhibitor with chemotherapeutic potential", Bioorg. Med. Chem. Lett. (2005), 15, 4717-4721. PDF
  85. O.A. Andersen, M.J. Dixon, I.M. Eggleston, and D.M.F. van Aalten, "Natural product family 18 chitinase inhibitors", Nat. Prod. Rep. (2005), 22, 563-579. PDF
  86. D.E. Blair, A.W. Schuettelkopf, J.I. MacRae, and D.M.F. van Aalten, "Structure and metal-dependent mechanism of peptidoglycan deacetylase, a streptococcal virulence factor", Proc. Natl. Acad. Sci. USA (2005), 102, 15429-15434. PDF
  87. 2006

  88. S.R. Wickramasinghe, K.A. Inglis, J.E. Urch, S. Mueller, D.M.F. van Aalten, and A.H. Fairlamb, "Kinetic, inhibition and structural studies on 3-oxoacyl-ACP reductase from Plasmodium falciparum, a key enzyme in fatty acid biosynthesis", Biochem. J. (2006), 393, 447-457. PDF
  89. M. Jaleel, F. Villa, M. Deak, R. Toth, A.R. Prescott, D.M.F. van Aalten, and Dario R. Alessi, "The ubiquitin-associated domain of AMPK-related kinases regulates conformation and LKB1-mediated phosphorylation and activation", Biochem. J. (2006), 394, 545-555. PDF + Commentary PDF
  90. F.V. Rao, H.C. Dorfmueller, F. Villa, M. Allwood, I.M. Eggleston, and D.M.F. van Aalten, "Structural insights into mechanism and inhibition of eukaryotic O-GlcNAc hydrolysis", EMBO J. (2006), 25, 1569-1578. PDF + Commentary PDF
  91. H. Attrill, H. Takazawa, S. Witt, S. Kelm, R. Isecke, R. Brossmer, T. Ando, H. Ishida, M. Kiso, P.R. Crocker, and D.M.F. van Aalten, "The structure of Siglec-7 in complex with sialosides: leads for rational structure-based inhibitor design", Biochem. J. (2006), 397, 271-278. PDF
  92. A.W. Schuettelkopf, G. Hamilton, C. Watts, and D.M.F. van Aalten, "Structural basis of reduction-dependent activation of human Cystatin F", J. Biol. Chem. (2006), 281, 16570-16575. PDF
  93. D.E. Blair, O. Hekmat, A.W. Schuettelkopf, B. Shrestha, K. Tokuyasu, S.G.Withers, and D.M.F. van Aalten, "Structure and mechanism of chitin deacetylase from the fungal pathogen Colletotrichum lindemuthianum", Biochemistry (2006), 45, 9416-9426. PDF
  94. A.W. Schuettelkopf, O.A. Andersen, F.V. Rao, M. Allwood, C. Lloyd, I.M.Eggleston, and D.M.F. van Aalten, "Screening-based discovery and structural dissection of a novel family 18 chitinase inhibitor", J. Biol. Chem. (2006), 281, 27278-27285. PDF
  95. S.H. Conner, G. Kular, M. Peggie, S. Shepherd, A.W. Schuettelkopf, P. Cohen, and D.M.F. van Aalten, "TAK1-binding protein 1 is a pseudophosphatase", Biochem. J. (2006), 399, 427-434. PDF
  96. M.J. Dixon, O.A. Andersen, D.M.F. van Aalten, and Ian M. Eggleston, "First synthesis of argadin: a nanomolar inhibitor of family-18 chitinases", Eur. J. Org. Chem. (2006), 22, 5002-5006. PDF
  97. H. Attrill, A. Imamura, R.S. Sharma, M. Kiso, P.R. Crocker, and D.M.F. van Aalten, "Siglec-7 undergoes a major conformational change when complexed with the α2,8-disialylganglioside GT1b", J. Biol. Chem. (2006), 281, 32774-32783. PDF
  98. H.C. Dorfmueller, V.S. Borodkin, M. Schimpl, S.M. Shepherd, N.A. Shpiro, and D.M.F. van Aalten, "GlcNAcstatin: a picomolar, selective O-GlcNAcase inhibitor that modulates intracellular O-GlcNAcylation levels", J. Am. Chem. Soc. (2006), 128, 16484-16485. PDF + Commentary PDF

  99. 2007

  100. J. Taskinen, D.M.F. van Aalten, J. Knudsen, and R.K. Wierenga, "High resolution crystal structures of unliganded and liganded human liver ACBP reveal a new mode of binding for the acyl-CoA ligand", Proteins (2007), 66, 220-238. PDF
  101. S.J. Mills, D. Komander, M.N. Trusselle, S.T. Safrany, D.M.F. van Aalten, and B.L.V. Potter, "Novel inositol phospholipid headgroup surrogate crystallized in the pleckstrin homology domain of protein kinase Bα", ACS Chem. Biol. (2007), 2, 242-246. PDF
  102. R. Hurtado-Guerrero and D.M.F. van Aalten, "Structure of Saccharomyces cerevisiae chitinase 1 and screening-based discovery of potent inhibitors", Chem. Biol. (2007), 14, 589-599. PDF
  103. F. Villa, J. Goebel, F.H. Rafiqi, M. Deak, J. Thastrup, D.R. Alessi, and D.M.F. van Aalten, "Structural insights into the recognition of substrates and activators by the OSR1 kinase", EMBO Rep. (2007), 8, 839-845. PDF
  104. M.B. Allwood, B. Cannan, D.M.F. van Aalten, and I.E. Eggleston, "Efficient synthesis of 1,3,7-substituted xanthines by a safety-catch protection strategy", Tetrahedron (2007), 50, 12294-12302. PDF
  105. R. Hurtado-Guerrero, O. Raimi, S. Shepherd, and D.M.F. van Aalten, "Glucose-6-phosphate as a probe for the glucosamine-6-phosphate N-acetyltransferase Michaelis complex", FEBS Lett. (2007), 581, 5597-5600. PDF
  106. 2008

  107. O.A. Andersen, A. Nathubhai, M.J. Dixon, I.M. Eggleston, and D.M.F. van Aalten, "Structure-based dissection of the natural product cyclopentapeptide chitinase inhibitor argifin", Chem. Biol. (2008), 15, 295-301. PDF + Commentary PDF
  108. J.R. Bayascas, S. Wullschleger, K. Sakamoto, J.M. Garcia-Martinez, C. Clacher, D. Komander, D.M.F. van Aalten, K.M. Boini, F. Lang, C. Lipina, L. Logie, C. Sutherland, J.A. Chudek, J. van Diepen, P.J. Voshol, J.M. Lucocq, and D.R. Alessi, "Mutation of PDK1 PH domain inhibits PKB/Akt leading to small size and insulin-resistance", Mol. Cell. Biol. (2008), 28, 3258-3272. PDF
  109. S. Pathak, H.C. Dorfmueller, V.S. Borodkin, and D.M.F. van Aalten, "Chemical dissection of the link between streptozotocin, O-GlcNAc and pancreatic cell death", Chem. Biol. (2008), 15, 799-807. PDF
  110. R. Hurtado-Guerrero, O.G. Raimi, J. Min, H. Zeng, L. Vallius, S.M. Shepherd, A.F.M. Ibrahim, H. Wu, A.N. Plotnikov, and D.M.F. van Aalten, "Structural and kinetic differences between human and Aspergillus fumigatus D-glucosamine-6-phosphate N-acetyltransferase", Biochem. J. (2008), 415, 217-223. PDF
  111. D. Lamb, A.W. Schuettelkopf, D.M.F. van Aalten, and D.W. Brighty, "Highly specific inhibition of leukaemia virus membrane fusion by interaction of peptide antagonists with a conserved region of the coiled coil ofenvelope", Retrovirology (2008), 5, 70. PDF
  112. F. Villa, M. Deak, D.R. Alessi, and D.M.F. van Aalten, "Structure of the OSR1 kinase, a hypertension drug target", Proteins (2008), 73, 1082-1087. PDF
  113. A. Clarke, R. Hurtado-Guerrero, S. Pathak, A.W. Schuettelkopf, V. Borodkin, S.M. Shepherd, A.F.M. Ibrahim, and D.M.F. van Aalten, "Structural insights into mechanism and specificity of O-GlcNAc transferase", EMBO J. (2008), 27, 2780-2788. PDF + Commentary PDF
  114. R. Hurtado-Guerrero, H.C. Dorfmueller, and D.M.F. van Aalten, "Molecular mechanisms of O-GlcNAcylation", Curr. Opin. Struct. Biol. (2008), 18, 551-557. PDF
  115. D.M.F. van Aalten and N.C.J. Strynadka,"Putting glycobiology on a structural footing", Curr. Opin. Struct. Biol. (2008), 18, 525-526. PDF

  116. 2009

  117. M.J. Dixon, A. Nathubhai, O.A. Andersen, D.M.F. van Aalten, and I.M. Eggleston, "Solid-phase synthesis of cyclic peptide chitinase inhibitors: SAR of the argifin scaffold", Org. Biomol. Chem. (2009), 7, 259-268. PDF Pubmed
  118. D.M. Deng, J.E. Urch, J.M. ten Cate, V.A. Rao, D.M.F. van Aalten, and W. Crielaard, "Streptococcus mutans SMU.623c codes for a functional, metal-dependent polysaccharide deacetylase that modulates interactions with salivary agglutinin", J. Bact. (2009), 191, 392-402. PDF Pubmed
  119. R. Hurtado-Guerrero, A.W. Schuettelkopf, I. Mouyna, A.F.M. Ibrahim, S. Shepherd, T. Fontaine, J.P. Latge, and D.M.F. van Aalten, "Molecular mechanisms of yeast cell wall glucan remodeling", J.Biol.Chem. (2009), 284, 8461-8469. PDF  Pubmed
  120. H.C. Dorfmueller, V.S. Borodkin, M Schimpl, and D.M.F. van Aalten, "GlcNAcstatins are nanomolar inhibitors of human O-GlcNAcase inducing cellular hyper-O-GlcNAcylation", Biochem.J. (2009), 420, 221-227. PDF  Pubmed
  121. J.E. Urch, R. Hurtado-Guerrero, D. Brosson, Z. Liu, V.G.H. Eijsink, C. Texier, and D.M.F. van Aalten, "Structural and functional characterization of a putative polysaccharide deacetylase of the human parasite Encephalitozoon cuniculi", Prot. Sci. (2009), 18, 1197-1209. PDF  Pubmed
  122. E. Zeqiraj, B.M. Filippi, S. Goldie, I. Navratilova, J. Boudeau, M. Deak, D.R. Alessi, and D.M.F. van Aalten, "ATP and MO25α regulate the conformational state of the STRADα pseudokinase and activation of the LKB1 tumour suppressor", PLoS Biol. (2009), 7, e1000126. PDF  Pubmed
  123. E. Zeqiraj, B.M. Filippi, M. Deak, D.R. Alessi and D.M.F. van Aalten, "Structure of the LKB1-STRAD-MO25 complex reveals an allosteric mechanism of kinase activation", Science (2009), 326, 1707-1711. PDF  Pubmed

  124. 2010

  125. H.C. Dorfmueller and D.M.F. van Aalten, "Screening-based discovery of drug-like O-GlcNAcase inhibitor scaffolds", FEBS Lett. (2010), 584, 694-700. PDF  Pubmed
  126. R. Hurtado-Guerrero, T. Zusman, S. Pathak, A.F.M. Ibrahim, S. Shepherd, A. Prescott, G. Segal and D.M.F. van Aalten, "Molecular mechanism of elongation factor 1A inhibition by a Legionella pneumophila glycosyltransferase", Biochem.J. (2010), 426, 281-292. PDF  Pubmed
  127. J.A. Frearson, S. Brand, S.P. McElroy, L.A.T. Cleghorn, O. Smid, L. Stojanovski, H.P. Price, M.L.S. Guther, L.S. Torrie, D.A. Robinson, I. Hallyburton, C.P. Mpamhanga, J.A. Brannigan, A.J. Wilkinson, M. Hodgkinson, R. Hui, W. Qiu, O.G. Raimi, D.M.F. van Aalten, R. Brenk, I.H. Gilbert, K.D. Read, A.H. Fairlamb, M.A.J. Ferguson, D.F. Smith and P.G. Wyatt, "N-myristoyltransferase inhibitors as new leads to treat sleeping sickness", Nature (2010), 464, 728-732. PDF +  Commentary PDF  Pubmed
  128. V.S. Borodkin and D,M.F. van Aalten, "An efficient and versatile synthesis of GlcNAcstatins - potent and selective O-GlcNAcase inhibitors built on the tetrahydroimidazo[1,2-a]pyridine scaffold", Tetrahedron (2010), 66, 7838-7849. PDF  Pubmed
  129. C.L. Rush, A.W. Schuettelkopf, R. Hurtado-Guerrero, D.E. Blair, A.F.M. Ibrahim, S. Desvergnes, I.M. Eggleston and D.M.F. van Aalten, "Natural product-guided discovery of a fungal chitinase inhibitor", Chem.Biol. (2010), 17, 1275-1281. PDF  Pubmed
  130. H.C. Dorfmueller, V.S. Borodkin, M. Schimpl, X. Zheng, R. Kime, K. D. Read and D.M.F. van Aalten, "Cell-penetrant, nanomolar O-GlcNAcase inhibitors selective against lysosomal hexosaminidases", Chem.Biol. (2010), 17, 1250-1255. PDF  Pubmed
  131. A.W. Schuettelkopf, L. Gros, D.E Blair, J.A. Frearson, D.M.F. van Aalten and I. Gilbert, "Acetazolamide-based fungal chitinase inhibitors", Bioorg.Med.Chem. (2010), 18, 8334-8340. PDF  Pubmed
  132. M. Schimpl, A.W. Schuettelkopf, V.S. Borodkin and D.M.F. van Aalten, "Human O-GlcNAcase binds substrates in a conserved peptide recognition groove", Biochem.J. (2010), 432, 1-7. PDF  Pubmed
  133. E. Zeqiraj and D.M.F. van Aalten, "Pseudokinases - remnants of evolution or key allosteric regulators?", Curr.Opin.Struct.Biol. (2010), 20, 772-781. PDF  Pubmed

  134. 2011

  135. D. Lamb, A.W. Schuettelkopf, D.M.F. van Aalten and D.W. Brighty, "Charge-surrounded pockets and electrostatic interactions with small ions modulate the activity of retroviral fusion proteins", PLOS Pathog. (2011), 7, e1001268. PDF  Pubmed
  136. H.C. Dorfmueller, V.S. Borodkin, D.E. Blair, S. Pathak, I. Navratilova and D.M.F. van Aalten, "Substrate and product analogues as human O-GlcNAc transferase inhibitors", Amino Acids (2011), 40, 781-792. PDF  Pubmed
  137. L.M. Gay, X. Zheng and D.M.F. van Aalten, "O-GlcNAc transfer : size matters", Nature Chem.Biol. (2011), 7, 134-135. PDF  Pubmed
  138. A.W. Schuettelkopf, O.A. Andersen, F.V. Rao, M. Allwood, C.L. Rush, I.M. Eggleston and D.M.F. van Aalten, "Bisdionin C – a rationally designed, submicromolar inhibitor of family 18 chitinases", ACS Med.Chem.Lett. (2011), 2, 428-432. PDF
  139. T.E. Sutherland, O.A. Andersen, M. Betou, I.M. Eggleston, R.M. Maizels, D.M.F. van Aalten* and J.E. Allen*, "Analysing airway inflammation with chemical biology: dissection of acidic mammalian chitinase function with a selective drug-like inhibitor", Chem.Biol. (2011), 18, 569-579. (* co-corresponding authors). PDF  Pubmed
  140. D. Mariappa, K. Sauert, K. Mariño, D. Turnock, R. Webster, D.M.F. van Aalten, M.A.J. Ferguson and H.A.J. Mueller, "Protein O-GlcNAcylation is required for Fibroblast Growth Factor signaling in Drosophila", Sci.Signal. (2011), 4, ra89. PDF + Commentary PDF  Pubmed
  141. H.I. Woodroof, J.H. Pogson, M. Begley, L.C. Cantley, M. Deak, D.G. Campbell, D.M.F. van Aalten, A.J. Whitworth, D.R. Alessi and M.M.K. Muqit, "Discovery of catalytically active orthologues of the Parkinson’s disease kinase PINK1: analysis of substrate specificity and impact of mutations", Open Biol. (2011), 1, 110012. PDF Pubmed

  142. 2012

  143. E. Wong, G. Vaaje-Kolstad, A. Ghosh, R. Hurtado-Guerrero, P.V. Konarev, A.F.M. Ibrahim, D.I. Svergun, V.G.H. Eijsink, N.S. Chatterjee and D.M.F. van Aalten, “The Vibrio cholerae colonization factor GbpA possesses a modular structure that governs binding to different host surfaces”, PLOS Pathog. (2012), 8, e1002373. PDF  Pubmed
  144. M. Schimpl, V.S. Borodkin, L.J. Gray and D.M.F. van Aalten, "Synergy of peptide and sugar in O-GlcNAcase substrate recognition", Chem.Biol. (2012), 19, 173-176. PDF  Pubmed
  145. S. Pathak, V.S. Borodkin, O. Albarbarawi, D.G. Campbell, A. Ibrahim and D.M.F. van Aalten, "O-GlcNAcylation of TAB1 modulates TAK1-mediated cytokine release", EMBO J. (2012), 31, 1394-1404. PDF  Pubmed
  146. M.J. Dixon, A. Gray, M. Schenning, M. Agacan, W. Tempel, Y. Tong, L. Nedyalkova, H.-W. Park, N.R. Leslie, D.M.F. van Aalten, C.P. Downes and I.H. Batty, "IQGAP proteins reveal an atypical phosphoinositide (aPI) binding domain with a pseudo C2 domain fold", J.Biol.Chem. (2012), 287, 22483-22496. PDF  Pubmed
  147. G.A. Penman, D.E.A. Lockhart, A. Ferenbach and D.M.F. van Aalten, "Purification, crystallization and preliminary X-ray diffraction data of UDP-galactopyranose mutase from Aspergillus fumigatus", Acta Cryst. F (2012), F68, 705-708. PDF  Pubmed
  148. H.C. Dorfmueller, W. Fang, F.V. Rao, D.E. Blair, H. Attrill and D.M.F van Aalten, "Structural and biochemical characterization of a trapped coenzyme A adduct of Caenorhabditis elegans glucosamine-6-phosphate N-acetyltransferase", Acta Cryst. D (2012), D68, 1019-1029. PDF  Pubmed
  149. M. Schimpl, C.L. Rush, M. Betou, I.M. Eggleston, A.D. Recklies and D.M.F van Aalten, "Human YKL-39 is a pseudo-chitinase with retained chitooligosaccharide-binding properties", Biochem.J. (2012), 446, 149-157. PDF  Pubmed
  150. M. Schimpl, X. Zheng, V.S. Borodkin, D.E. Blair, A.T. Ferenbach, A.W. Schuettelkopf, I. Navratilova, T. Aristotelous, O. Albarbarawi, D.A. Robinson, M.A. MacNaughtan and D.M.F. van Aalten, "O-GlcNAc transferase invokes nucleotide sugar pyrophosphate participation in catalysis", Nature Chem.Biol. (2012), 8, 969-974. PDF + Commentary PDF  Pubmed
  151. 2013

  152. H. Hahne, N. Sobotzki, T. Nyberg, D. Helm, V.S. Borodkin, D.M.F. van Aalten, B. Agnew and B. Kuster, "Proteome wide purification and identification of O-GlcNAc-modified proteins using click chemistry and mass spectrometry", J.Proteome Res. (2013), 12, 927-936. PDF  Pubmed 23301498
  153. D. Mariappa, S. Pathak and D.M.F. van Aalten, "A sweet TET-à-tête - synergy of TET proteins and O-GlcNAc transferase in transcription", EMBO J. (2013), 32, 612-613. PDF  Pubmed 23403924
  154. W. Fang, T. Du, O.G. Raimi, R. Hurtado-Guerrero, M.D. Urbaniak, A.F.M. Ibrahim, M.A.J. Ferguson, C. Jin and D.M.F. van Aalten, "Genetic and structural validation of Aspergillus fumigatus UDP-N-acetylglucosamine pyrophosphorylase as an antifungal target", Mol.Microbiol. (2013), 89, 479-493. PDF  Pubmed 23750903
  155. L. Hobley, A. Ostrowski, F.V. Rao, K.M. Bromley, M. Porter, A.R. Prescott, C. MacPhee, D.M.F. van Aalten and N.R. Stanley-Wall, "BslA is a self-assembling bacterial hydrophobin that coats the Bacillus subtilis biofilm", Proc.Natl.Acad.Sci.USA (2013), 110, 13600-13605. PDF +  Commentary PDF  Pubmed 23904481
  156. W. Fang, T. Du, O.G. Raimi, R. Hurtado-Guerrero, K. Mariño, A.F.M. Ibrahim, O. Albarbarawi, M.A.J. Ferguson, C. Jin and D.M.F. van Aalten, "Genetic and structural validation of Aspergillus fumigatus N-acetylphosphoglucosamine mutase as an antifungal target", Biosci.Rep. (2013), 33, 689-699. PDF  Pubmed 23844980
  157. M.D. Urbaniak, I.T. Collie, W. Fang, T. Aristotelous, S. Eskilsson, O.G. Raimi, J. Harrison, I. Hopkins Navratilova, J.A. Frearson, D.M.F. van Aalten and M.A.J. Ferguson, "A novel allosteric inhibitor of the uridine diphosphate N-acetylglucosamine pyrophosphorylase from Trypanosoma brucei", ACS Chem.Biol. (2013), 8, 1981-1987. PDF  Pubmed 23834437
  158. A. Striebeck, D.A. Robinson, A.W. Schuettelkopf and D.M.F. van Aalten, "Yeast Mnn9 is both a priming glycosyltransferase and an allosteric activator of mannan biosynthesis", Open Biol. (2013), 3, 130022. PDF  Pubmed 24026536
  159. F.V. Rao, A.W. Schuettelkopf, H.C. Dorfmueller, A.T. Ferenbach, I. Navratilova and D.M.F. van Aalten, "Structure of a bacterial putative acetyltransferase defines the fold of the human O-GlcNAcase C-terminal domain", Open Biol. (2013), 3, 130021. PDF + Journal cover PDF Pubmed 24088714
  160. A. Ostrowski and D.M.F. van Aalten, "Chemical tools to probe cellular O-GlcNAc signalling", Biochem.J. (2013), 456, 1-12. PDF Pubmed 24156473
  161. 2014

  162. V.S. Borodkin, M. Schimpl, M. Gundogdu, K. Rafie, H.C. Dorfmueller, D.A. Robinson and D.M.F. van Aalten, "Bisubstrate UDP-peptide conjugates as human O-GlcNAc transferase inhibitors", Biochem.J. (2014), 457, 497-502. PDF Pubmed 24256146
  163. D.E.A. Lockhart, A.W. Schuettelkopf, D.E. Blair and D.M.F. van Aalten, "Screening-based discovery of Aspergillus fumigatus plant-type chitinase inhibitors", FEBS Lett. (2014), 588, 3282-3290. PDF Pubmed 25063338
  164. H.C. Dorfmueller, A.T. Ferenbach, V.S. Borodkin and D.M.F. van Aalten, "A structural and biochemical model of processive chitin synthesis", J.Biol.Chem. (2014), 289, 23020-23028. PDF Pubmed 24942743
  165. C.M. Speakman, T.C.E. Domke, W. Wongpaiboonwattana, K.L. Sanders, M. Mudaliar, D.M.F. van Aalten, G.J. Barton, and M.P. Stavridis, "Elevated O-GlcNAc levels activate epigenetically repressed genes and delay mouse ESC differentiation without affecting naive to primed cell transition", Stem Cells (2014), 32, 2605-2615. PDF Pubmed 24898611
  166. J. Alonso, M. Schimpl and D.M.F. van Aalten, "O-GlcNAcase : promiscuous hexosaminidase or key regulator of O-GlcNAc signalling?", J.Biol.Chem. (2014), 289, 34433-34439. PDF Pubmed 25336650
  167. S. Brand, N.R. Norcross, S. Thompson, J.R. Harrison, V.C. Smith, D.A. Robinson, L.S. Torrie, S.P. McElroy, I. Hallyburton, S. Norval, P. Scullion, L. Stojanovski, F.R.C. Simeons, D. van Aalten, J.A. Frearson, R. Brenk, A.H. Fairlamb, M.A.J. Ferguson, P.G. Wyatt, I.H. Gilbert and K.D. Read, "Lead Optimization of a Pyrazole Sulfonamide Series of Trypanosoma brucei N‐Myristoyltransferase Inhibitors: Identification and Evaluation of CNS Penetrant Compounds as Potential Treatments for Stage 2 Human African Trypanosomiasis", J.Med.Chem. (2014), 57, 9855−9869. PDF Pubmed 25412409
  168. 2015

  169. N. Zhang, S.L. Gordon, M.J. Fritsch, N. Esoof, D.G. Campbell, R. Gourlay, S. Velupillai, T. Macartney, M. Peggie, D.M.F. van Aalten, M.A. Cousin and D.R. Alessi, "Phosphorylation of synaptic vesicle protein 2A at Thr84 by casein kinase 1 family kinases controls the specific retrieval of Synaptotagmin-1", J.Neurosci. (2015), 35, 2492–2507. PDF Pubmed 25673844
  170. N. Selvan, D. Mariappa, H.W.P. van den Toorn, A.J.R. Heck, A.T. Ferenbach and D.M.F. van Aalten, "The early metazoan Trichoplax adhaerens possesses a functional O-GlcNAc system", J.Biol.Chem. (2015), 290, 11969-11982. PDF Pubmed 25778404
  171. W. Fang, D.A. Robinson, O.G. Raimi, D.E. Blair, J.R. Harrison, D.E.A. Lockhart, L.S. Torrie, G.F. Ruda, P.G. Wyatt, I.H. Gilbert and D.M.F. van Aalten, "N-myristoyltransferase is a cell wall target in Aspergillus fumigatus", ACS Chem.Biol. (2015), 10, 1425−1434. PDF Pubmed 25706802
  172. T. Jank, S. Eckerle, M. Steinemann, C. Trillhaase, M. Schimp, S. Wiese, D.M.F. van Aalten, W. Driever and K. Aktories, "Tyrosine glycosylation of Rho by Yersinia toxin impairs blastomere cell behaviour in zebrafish embryos", Nature Comms. (2015), 6, 7807. PDF Pubmed 26190758
  173. A. Kazlauskaite, R.J. Martínez-Torres, S. Wilkie, A. Kumar, J. Peltier, A. Gonzalez, C. Johnson, J. Zhang, A.G. Hope, M. Peggie, M. Trost, D.M.F. van Aalten, D.R. Alessi, A.R. Prescott, A. Knebel, H. Walden and M.M.K. Muqit, "Binding to serine 65-phosphorylated ubiquitin primes Parkin for optimal PINK1-dependent phosphorylation and activation", EMBO Rep. (2015), 16, 939-954. PDF Pubmed 26116755
  174. S. Pathak, J. Alonso, M. Schimpl, K. Rafie, D.E. Blair, V.S. Borodkin, A.W. Schuettelkopf, O. Albarbarawi and D.M.F. van Aalten, "The active site of O-GlcNAc transferase imposes constraints on substrate sequence", Nat.Struct.Mol.Biol. (2015), 22, 744-750. PDF Pubmed 26237509
  175. D. Mariyappa, N. Selvan, V.S. Borodkin, J. Alonso, A.T. Ferenbach, C. Shepherd, I. Hopkins-Navratilova and D.M.F. van Aalten, "A mutant O-GlcNAcase as a probe to reveal global dynamics of protein O-GlcNAcylation during Drosophila embryonic development", Biochem.J. (2015), 470, 255-262. PDF + Commentary PDF Pubmed 26348912
  176. S.L. van der Beek, Y. Le Breton, A.T. Ferenbach, R.N. Chapman, D.M.F. van Aalten, I. Navratilova, G.J. Boons, K.S. McIver, N.M. van Sorge and H.C. Dorfmueller, "GacA is essential for Group A Streptococcus and defines a new class of monomeric dTDP-4-dehydrorhamnose reductases (RmlD)", Mol.Micro. (2015), 98, 946–962. PDF Pubmed 26278404
  177. A. Ostrowski, M. Gundogdu, A.T. Ferenbach, A.A. Lebedev and D.M.F. van Aalten, "Evidence for a functional O-GlcNAc system in the thermophilic bacterium Thermobaculum terrenum", J.Biol.Chem. (2015), 51, 30291–30305. PDF Pubmed 26491011
  178. D. Mariappa, X. Zheng, M. Schimpl, O. Raimi, A.T. Ferenbach, H.A.J. Mueller and D.M.F. van Aalten, "Dual functionality of O-GlcNAc transferase is required for Drosophila development", Open Biol. (2015), 5, 150234. PDF Pubmed 26674417
  179. 2016

  180. R. Trapannone, K. Rafie and D.M.F. van Aalten, "O-GlcNAc transferase inhibitors: current tools and future challenges", Biochem.Soc.Trans. (2016), 44, 88-93. PDF Pubmed 26862193
  181. L. Raich, V.S. Borodkin, W. Fang, J. Castro, D.M.F. van Aalten, R. Hurtado-Guerrero and C. Rovira, "A trapped covalent intermediate of a glycoside hydrolase on the pathway to transglycosylation. Insights from experiments and QM/MM simulations", J.Am.Chem.Soc. (2016), 38, 3325−3332. PDF Pubmed 26859322
  182. V. Kapuria, U.F. Roehrig, T. Bhuiyan, V.S. Borodkin, D.M.F. van Aalten, V. Zoete and W. Herr, "Proteolysis of HCF-1 by Ser/Thr glycosylation-incompetent O-GlcNAc transferase:UDP-GlcNAc complexes", Genes Dev. (2016), 30, 960-972. PDF Pubmed 27056667
  183. M. Swamy, S. Pathak, K.M. Grzes, S. Damerow, L.V. Sinclair, D.M.F. van Aalten and D.A. Cantrell, "Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy", Nature Immunology (2016), 17, 712-20. PDF Pubmed 27111141
  184. R. Trapannone, D. Mariappa, A.T. Ferenbach and D.M.F. van Aalten, "Nucleocytoplasmic human O-GlcNAc transferase is sufficient for O-GlcNAcylation of mitochondrial proteins", Biochem.J. (2016), 473 (12) 1693-1702. PDF Pubmed 27048592
  185. 2017

  186. Z. Liu, L.M. Gay, T.R. Tuveng, J.W. Agger, B. Westereng, G. Mathiesen, S.J. Horn, G. Vaaje-Kolstad, D.M.F. van Aalten and V.G.H. Eijsink, "Structure and function of a broad- specificity chitin deacetylase from Aspergillus nidulans FGSC A4", Sci.Rep. (2017), 7: 1746. PDF Pubmed 00000000
  187. N. Selvan, R. Williamson, D. Mariappa, D.G. Campbell, R. Gourlay, A.T. Ferenbach, T. Aristotelous, I. Hopkins-Navratilova, M. Trost and D.M.F. van Aalten, "Native enrichment of the Drosophila O-GlcNAc proteome reveals candidate conveyors of the supersex combs phenotype", Nature Chem.Biol. (2017), in press.
  188. K. Rafie, O. Raimi, A.T. Ferenbach, V.S. Borodkin, V. Kapuria and D.M.F. van Aalten, "Recognition of a glycosylation substrate by the O-GlcNAc transferase TPR repeats", Open Biol. (2017), in press.
  189. A.P. Willems, M. Gundogdu, M.J.E. Kempers, J.C. Giltay, R. Pfundt, M. Elferink, B.F. Loza, J. Fuijkschot, A.T. Ferenbach, K.L.I. van Gassen, D.M.F. van Aalten* and D.J. Lefeber* (* joint corresponding authors), "Mutations in N-acetylglucosamine (O-GlcNAc) transferase in patients with X-linked intellectual disability", J.Biol.Chem. (2017), in press.
  190. A.L. Leney, K. Rafie, D.M.F. van Aalten and A. Heck, "Direct monitoring of protein O-GlcNAcylation by high-resolution native mass spectrometry", ACS Chem.Biol. (2017), in press.